|
 |
TravoprostThis page contains recent news articles, when available, and an overview of Travoprost but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Glaucoma product sales increased 26.9% and were led by higher global sales of Travatan (travoprost) and Azopt (brinzolamide), as well as continued market OSN SuperSite (subscription), Hyperemia in Glaucoma Patients - Jul 25, 2008 Conjunctival hyperemia in healthy subjects after short-term dosing with latanoprost, bimatoprost, and travoprost. Am J Ophthalmol. 2003;135:314-320. Medscape (subscription) Advances in Glaucoma Treatment - May 30, 2008 Researchers from the New York Eye and Ear Institute [1] compared contamination rates in the bottles of 82 patients first assigned travoprost, Medscape (subscription) Novartis takes step toward global leadership in eye care industry - May 23, 2008 Among Alcon’s most successful lines are Travatan (travoprost) for glaucoma, Vigamox (moxifloxacin 0.5%) for ocular infections and Opti-Free contact lens OSN SuperSite (subscription), Alcon's First Quarter Sales Rise 16.2 Percent; Net Income ... - 23 Apr 2008 A new drug application for DuoTravTM ophthalmic solution, a fixed combination of travoprost and timolol, has been filed with the Ministry of Health, WELT ONLINE, Alcon to build manufacturing plant in Singapore - Apr 15, 2008 Travatanz (travoprost ophthalmic solution), Patanol (olopatadine) and Vigamox (moxifloxacin) are among the pharmaceuticals to be manufactured on the site, In-PharmaTechnologist.com, Novartis eyes new markets by taking Alcon stake - Apr 7, 2008 One in 10 people over the age of 80 suffer from glaucoma and consequently demand for drugs such as Alcon's Travatan (travoprost) looks set to rise. In-PharmaTechnologist.com, Adjunctive Medications to Lower Intraocular Pressure Go Head-to ... - Nov 13, 2007 The prostaglandins being used were latanoprost (n = 35), bimatoprost (n = 71), and travoprost (n = 14). The patients were also given brimonidine Purite (n DG News Alcon's preservative-free travoprost approved in Japan - Jul 31, 2007 OSN SuperSite (subscription),FORT WORTH, Texas — The Ministry of Health, Labor and Welfare in Japan has approved a preservative-free version of travoprost for treating glaucoma and Alcon's Treatment of Glaucoma and Ocular Hypertension, TRAVATANZ ... - Aug 1, 2007 PipelineReview.com (press release),Alcon, Inc. announced today that the Ministry of Health, Labor and Welfare in Japan has approved TRAVATANZ(TM) (travoprost ophthalmic solution) 0.004% for Alcon reports 12.3% increase in second quarter sales - Jul 26, 2007 OSN SuperSite (subscription),Glaucoma product sales increased 13.7% and were led by sales growth for Travatan (travoprost) products internationally and by sales of Azopt (brinzolamide). Comparing Bimatoprost Daily versus Every Two Days in Patients With ... - May 15, 2007 DG NewsThese results are not unlike what has been seen with other prostaglandin analogs -- travoprost and latanoprost -- both of which show a statistically Glaucoma Experts Determine That Reducing Intraocular Pressure ... - May 11, 2007 Medical News Today (press release),A retrospective analysis of the Xalatan Lumigan Travatan (XLT) study show that three prostaglandins, latanoprost, bimatoprost and travoprost reduce the Akorn, Azad Partner on 3 Glaucoma Drugs - Jan 9, 2007 Forbes,The three ophthalmic ANDA drugs, Latanoprost, Bimatoprost and Travoprost, are expected to be manufactured by Taejoon Pharmaceutical Co. Akorn and Azad Ink Gluacoma Deal - Jan 9, 2007 Genetic Engineering News (press release),The companies report that the products, Latanoprost, Bimatoprost, and Travoprost, have a total US market-size of $870 million, according to 2006 IMS data. Market Report -- In Play (AKN) - Jan 9, 2007 MSN Money...with Azad Pharma to develop and supply Latanoprost, Bimatoprost and Travoprost, three ophthalmic ANDA drug products for the treatment of glaucoma. Cheaper drugs good news for patients - Dec 2, 2006 Sydney Morning Herald,...diabetes patients will get rosiglitazone with metformin (Avandamet); and 10000 glaucoma patients will receive travoprost with timolo maleate (Duotrav). FDA Approvals: Risperdal/Risperdal M-TAB, Travatan Z, Rituxan Oct 24, 2006 ...the treatment of irritability associated with autistic disorder in pediatric patients aged 5 to 16 years, and a new formulation of travoprost 0.004% ophthalmic ... -Medscape (subscription) Look Out! Oct 24, 2006 The free confidential programme is available for glaucoma patients taking travoprost, patients join for free when they visit a glaucoma clinic. ... -50 Connect, Alcon's TRAVATAN(R) Z Solution Approved by FDA for Treatment of ... Sep 22, 2006 Announced today that the US Food and Drug Administration (FDA) has approved TRAVATAN(R) Z (travoprost ophthalmic solution) 0.004% for the reduction of elevated ... -PipelineReview.com Alcon's TRAVATAN(R) Z Solution Approved by FDA for Treatment of ... Sep 21, 2006 21, 2006--Alcon, Inc. (NYSE:ACL) announced today that the US Food and Drug Administration (FDA) has approved TRAVATAN(R) Z (travoprost ophthalmic solution ... -Business Wire Alcon Granted FDA Approval For Travatan Solution For Treatment Of ... Sep 21, 2006 The company added that travoprost ophthalmic solution or TRAVATAN Z reduces the elevated intraocular pressure in patients with open-angle glaucoma or ocular ... -Trading Markets Brinzolamide 1% Found More Effective Than Brimonidine 0.15% When ... May 1, 2006 ...efficacy of twice daily brimonidine 0.15% purite versus twice daily brinzolamide 1% ophthalmic suspension as additional therapy to travoprost 0.004% in eyes of ... - DG News NEW STUDY DEMONSTRATES A SINGLE COMPOUND AS EFFECTIVE AS A FIXED ... May 3, 2006 A comparison of latanoprost, bimatoprost and travoprost in patients with elevated intraocular pressure a 12-week randomised, masked-elevator, multicentre study ... - ITNews (BW) Alcon's First Quarter Sales Rise 8.1 Percent, Net Earnings ... Apr 24, 2006 DuoTrav(TM), a fixed combination of travoprost 0.004% and timolol 0.5%, received a positive recommendation for approval in the European Union by the ... - Houston Chronicle Alcon Q1 Net Earnings Rise 18.5% Primarily On Healthy Sales Growth ... Apr 24, 2006 DuoTrav, a fixed combination of travoprost 0.004% and timolol 0.5%, received a positive recommendation for approval in the European Union by the Committee for ... - Trading Markets (BW) Alcon Receives Positive Opinion for DuoTrav(TM) Eye Drops ... Feb 24, 2006 Products for Human Use (CHMP) has adopted a positive opinion on the initial marketing authorization for DuoTrav(TM) solution (travoprost 0.004%/timolol 0.5%). ... - Houston Chronicle, CMPH - Initial Marketing Authorisation Applications,Europe ... Feb 24, 2006 ...-- Duotrav (travoprost/timolol maleate), Alcon Laboratories. Duotrav is an eye-drops solution, intended for the decrease of intraocular ... - Medical News Today, European Medicines Agency: Committee for Medicinal Products for ... Feb 23, 2006 Duotrav (travoprost/timolol maleate), Alcon Laboratories. Duotrav is an eye-drops solution, intended for the decrease of intraocular ... - PharmaLive.com, : |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2007 MONGABAY.COM |